Presentation ESC 2016 Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Patients With Non-ischemic Heart Failure Presenter: Javed Butler August 28, 2016 REGISTER for free or LOG IN to view this content Coronary Heart Failure Presentation ESC 2016 Up Next Presentation TCT 2012 Current Treatment and Outcome of Coronary In-Stent Restenosis – Report from the Swedish Angiography and Angioplasty Registry (SCAAR) Presenter: Torsten Schwalm January 03, 2012 More slides + Presentation TCT 2012 The Impact of XIENCE V® Everolimus-Eluting Coronary Stents on Health Status in COURAGE-Like Patients. Presenter: David R. Rutledge January 03, 2012 Presentation TCT 2012 Healing Responses After Bifurcation Stenting with the Dedicated TRYTON Side-Branch Stent in Combination with XIENCE V Stents: an Angiography and Optical Coherence Tomography Study. Presenter: Christophe L. Dubois January 03, 2012 We Recommend
Presentation TCT 2012 Current Treatment and Outcome of Coronary In-Stent Restenosis – Report from the Swedish Angiography and Angioplasty Registry (SCAAR) Presenter: Torsten Schwalm January 03, 2012
Presentation TCT 2012 The Impact of XIENCE V® Everolimus-Eluting Coronary Stents on Health Status in COURAGE-Like Patients. Presenter: David R. Rutledge January 03, 2012
Presentation TCT 2012 Healing Responses After Bifurcation Stenting with the Dedicated TRYTON Side-Branch Stent in Combination with XIENCE V Stents: an Angiography and Optical Coherence Tomography Study. Presenter: Christophe L. Dubois January 03, 2012